Starts in
000
days
00
hours
Welcome to Precision Medicine and the Future of Genomics 2024 Summit
We are excited to welcome all participants, partners, and supporters to PMFG 2024 as we celebrate a decade of advancements in precision medicine. As Chairs of this year’s summit, we are proud to have Sidra Medicine led the first precision medicine symposium in the Middle East since 2014, growing it into a hub for innovators in healthcare.
PMFG 2024 will be held from December 3-5, 2024, in Doha, focusing on Genomics for All, Precision Diagnostics, and Advanced Therapeutics. We look forward to insightful discussions and transformative collaborations. Thank you for joining us and see you in Doha!
PMFG 2024 Summit Organizing Chairs
Dr. Ammira Al-Shabeeb Akil / Prof. Khalid Fakhro
Chairs
Dr. Ammira Akil
Prof. Khalid Fakhro
Speakers
Dr. Nicolas Encina
Dr. Wan Yue
Dr. Raghib Ali
Dr. Chantal Mathieu
Dr. Manuela Battaglia
Dr. Carlos Bustamante
Under the Patronage of
Official Airline Partner
Exclusive offer to all participants attending the Prescision medicine and the future of genomics summit 2024
from any of our over 170 global destinations to Hamad International Airport - Doha. Search flights
from any of our over 170 global destinations to Hamad International Airport - Doha. Search flights
Target Audience
- Healthcare Professionals: Physicians, Nurses, Geneticists, Researchers, Clinicians
- Scientists and Researchers: Genomic Scientists, Biomedical Researchers, Bioinformaticians
- Industry Leaders: Pharma/Biotech Professionals, Healthcare Executives
- Academic Institutions: Faculty Members, Students in Healthcare and Genetics
- Policy Makers and Regulators: Government Officials, Regulatory Authorities
- Technology and Solution Providers: Genomic Sequencing Companies, Biotech and Healthcare IT
- Patient Advocates: Advocacy Group Representatives, Individuals focused on Precision Medicine
- International Delegates: Global Professionals and Researchers in Precision Medicine
Conference Pillars
Genomics for All: Screening From Newborns to Whole Population
- Develop and establish robust genomic screening initiatives for newborns to identify and address potential genetic conditions early in life.
- Evaluate Population-wide Genomic Data for Precision Medicine from population cohorts to enhance our understanding of genetic variations, susceptibility to diseases, and potential targets for precision medicine interventions.
- Discuss the potential impact of early genomic information on long-term health outcomes.
Precision Diagnostics in Rare and Complex Diseases
- Develop and implement advanced diagnostic technologies to improve the accuracy and efficiency of identifying rare and complex diseases at an early stage.
- Encourage the exploration and development of targeted therapies and precision interventions tailored to the unique genetic and molecular profiles associated with rare and complex diseases.
Next-Generation Therapeutics for Precision Medicine
- Showcase and discuss the latest advancements in personalized and precision therapies, including innovative treatment modalities, targeted therapies, and emerging technologies.
- Explore groundbreaking research and clinical trials that demonstrate the potential for customized treatment strategies to improve outcomes for individuals with rare and complex diseases. Emphasize the importance of staying abreast of cutting-edge developments to inform clinical practice and enhance patient care.
- Emphasize the integration of genomic data into clinical practice, fostering a deeper understanding of the genetic underpinnings of complex diseases and paving the way for more targeted and effective interventions.
Conference Objectives
The objectives aim to align with the pillars outlined in the summit program, emphasizing innovation, collaboration, and ethical considerations within the domains of newborn sequencing, population genomic screening, and advanced therapeutics in precision medicine.
- Elucidate advancements in newborn sequencing technologies, addressing implementation challenges and fostering discussions on best practices.
- Explore the potential long-term health impact of early genomic information, emphasizing the importance of early intervention and personalized care for newborns.
- Explore cutting-edge innovations in population screening, keeping attendees informed about large-scale genomic advancements.
- Investigate integrating genomic data into population health management, discuss effective utilization strategies within healthcare systems, and foster ethical conversations on large-scale genomic screening responsibly.
- Spotlight cutting-edge developments in personalized and precision therapies, showcasing the latest advancements contributing to more effective and targeted treatments.
- Facilitate discussions on the role of genomics in tailoring treatment plans for complex diseases, exploring how genomic insights can enhance therapeutic decision-making.
Welcome to Doha, Qatar’s ultramodern capital. Located in the east of the country, Doha is home to approximately 646,000 people from all over the world. It’s the country’s fastest-growing city and its business centre.
Doha’s tourism sector has evolved rapidly over the years, with key attractions and several museums of great importance gaining the spotlight.
Known for its exemplary hospitality, exquisite cuisine, unique shopping experiences and traditional souqs, along with a plethora of adventures and activities, Doha is growing rapidly, and offers something for all travellers.
Qatar Tourism
Welcome to Doha, Qatar’s ultramodern capital. Located in the east of the country, Doha is home to approximately 646,000 people from all over the world. It’s the country’s fastest-growing city and its business centre.
Doha’s tourism sector has evolved rapidly over the years, with key attractions and several museums of great importance gaining the spotlight.
Known for its exemplary hospitality, exquisite cuisine, unique shopping experiences and traditional souqs, along with a plethora of adventures and activities, Doha is growing rapidly, and offers something for all travellers.
